From: Identification of a RAD51B enhancer variant for susceptibility and progression to glioma
Genotypea | Patients (n = 402) No. (%) | Controls (n = 654) No. (%) | ORb (95%CI) | P |
---|---|---|---|---|
GG | 350 (87.94) | 540 (83.20) | 1.00 (reference) | |
GC | 45 (11.31) | 103 (15.87) | 0.66 (0.45–0.97) | 0.034 |
CC | 3 (0.75) | 6 (0.93) | 1.03 (0.25–4.22) | 0.964 |
GC + CC vs. GG | 0.68 (0.47–0.99) | 0.041 |